Sun Pharma launches ‘Sunkalp’

01 July 2021 | News

As a special tribute, announces various initiatives for the welfare of doctors, their families and the community

Sun Pharmaceutical Industries announced the launch of a special initiative ‘Sunkalp’ for the welfare of doctors, their families and the community. 


The initiatives will be rolled out in a phased manner. 


· Mental health support for doctors & their families

· Webinars for doctors on mental health by experts

· Donation of COVID-19 medicines (phase 2)

· Post Doctorate educational sponsorship (phase 2)

· Educational aid for children of doctors who lost their lives to COVID-19 (phase 2)


Sun Pharma has committed Rs 100 crores towards these initiatives, which includes a donation of COVID-19 medicines to communities at large through local & state government institutions. Sun Pharma has partnered with Mann Talks to provide doctors and their families with confidential emotional and psychological care by trained mental health professionals. Further, to educate doctors on mental health issues & enable them to take better self-care, multiple webinars will be held by experts. 


Sun Pharma will sponsor postgraduate medical students for medical and clinical research in various fields. More than 1000 young scholars will receive grants for their research projects. To pay homage to doctors who have lost their lives to COVID-19, Sun Pharma is setting up an Education Fund for their children. The company will provide educational grants to the affected families through this fund. The Sunkalp initiative is restricted to India. 


Kirti Ganorkar, CEO – India Business, Sun Pharma, said, “Indian healthcare professionals have faced unprecedented challenges during the pandemic, and their determination to fight against all odds inspires us every day. Sunkalp is a tribute to these heroes for their selfless acts of sacrifice and kindness. Through this initiative, we want to extend our gratitude to them and contribute to strengthening the healthcare ecosystem.” 



× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account